Mizuki Nishino, Hiroto Hatabu, F Stephen Hodi. Radiology 2019
Times Cited: 96
Times Cited: 96
Times Cited
Times Co-cited
Similarity
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics.
Lesley Seymour, Jan Bogaerts, Andrea Perrone, Robert Ford, Lawrence H Schwartz, Sumithra Mandrekar, Nancy U Lin, Saskia Litière, Janet Dancey, Alice Chen,[...]. Lancet Oncol 2017
Lesley Seymour, Jan Bogaerts, Andrea Perrone, Robert Ford, Lawrence H Schwartz, Sumithra Mandrekar, Nancy U Lin, Saskia Litière, Janet Dancey, Alice Chen,[...]. Lancet Oncol 2017
36
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E A Eisenhauer, P Therasse, J Bogaerts, L H Schwartz, D Sargent, R Ford, J Dancey, S Arbuck, S Gwyther, M Mooney,[...]. Eur J Cancer 2009
E A Eisenhauer, P Therasse, J Bogaerts, L H Schwartz, D Sargent, R Ford, J Dancey, S Arbuck, S Gwyther, M Mooney,[...]. Eur J Cancer 2009
33
Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria.
Jedd D Wolchok, Axel Hoos, Steven O'Day, Jeffrey S Weber, Omid Hamid, Celeste Lebbé, Michele Maio, Michael Binder, Oliver Bohnsack, Geoffrey Nichol,[...]. Clin Cancer Res 2009
Jedd D Wolchok, Axel Hoos, Steven O'Day, Jeffrey S Weber, Omid Hamid, Celeste Lebbé, Michele Maio, Michael Binder, Oliver Bohnsack, Geoffrey Nichol,[...]. Clin Cancer Res 2009
26
Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab.
Sree Harsha Tirumani, Nikhil H Ramaiya, Abhishek Keraliya, Nancy D Bailey, Patrick A Ott, F Stephen Hodi, Mizuki Nishino. Cancer Immunol Res 2015
Sree Harsha Tirumani, Nikhil H Ramaiya, Abhishek Keraliya, Nancy D Bailey, Patrick A Ott, F Stephen Hodi, Mizuki Nishino. Cancer Immunol Res 2015
23
PD-1 Inhibitor-Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course.
Mizuki Nishino, Nikhil H Ramaiya, Mark M Awad, Lynette M Sholl, Jennifer A Maattala, Myriam Taibi, Hiroto Hatabu, Patrick A Ott, Philippe F Armand, F Stephen Hodi. Clin Cancer Res 2016
Mizuki Nishino, Nikhil H Ramaiya, Mark M Awad, Lynette M Sholl, Jennifer A Maattala, Myriam Taibi, Hiroto Hatabu, Patrick A Ott, Philippe F Armand, F Stephen Hodi. Clin Cancer Res 2016
20
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Roger Sun, Elaine Johanna Limkin, Maria Vakalopoulou, Laurent Dercle, Stéphane Champiat, Shan Rong Han, Loïc Verlingue, David Brandao, Andrea Lancia, Samy Ammari,[...]. Lancet Oncol 2018
Roger Sun, Elaine Johanna Limkin, Maria Vakalopoulou, Laurent Dercle, Stéphane Champiat, Shan Rong Han, Loïc Verlingue, David Brandao, Andrea Lancia, Samy Ammari,[...]. Lancet Oncol 2018
19
Improved survival with ipilimumab in patients with metastatic melanoma.
F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel,[...]. N Engl J Med 2010
F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel,[...]. N Engl J Med 2010
17
Developing a common language for tumor response to immunotherapy: immune-related response criteria using unidimensional measurements.
Mizuki Nishino, Anita Giobbie-Hurder, Maria Gargano, Margaret Suda, Nikhil H Ramaiya, F Stephen Hodi. Clin Cancer Res 2013
Mizuki Nishino, Anita Giobbie-Hurder, Maria Gargano, Margaret Suda, Nikhil H Ramaiya, F Stephen Hodi. Clin Cancer Res 2013
17
Tumor Response Dynamics of Advanced Non-small Cell Lung Cancer Patients Treated with PD-1 Inhibitors: Imaging Markers for Treatment Outcome.
Mizuki Nishino, Suzanne E Dahlberg, Anika E Adeni, Christine A Lydon, Hiroto Hatabu, Pasi A Jänne, F Stephen Hodi, Mark M Awad. Clin Cancer Res 2017
Mizuki Nishino, Suzanne E Dahlberg, Anika E Adeni, Christine A Lydon, Hiroto Hatabu, Pasi A Jänne, F Stephen Hodi, Mark M Awad. Clin Cancer Res 2017
30
Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab.
F Stephen Hodi, Wen-Jen Hwu, Richard Kefford, Jeffrey S Weber, Adil Daud, Omid Hamid, Amita Patnaik, Antoni Ribas, Caroline Robert, Tara C Gangadhar,[...]. J Clin Oncol 2016
F Stephen Hodi, Wen-Jen Hwu, Richard Kefford, Jeffrey S Weber, Adil Daud, Omid Hamid, Amita Patnaik, Antoni Ribas, Caroline Robert, Tara C Gangadhar,[...]. J Clin Oncol 2016
15
Monitoring immune-checkpoint blockade: response evaluation and biomarker development.
Mizuki Nishino, Nikhil H Ramaiya, Hiroto Hatabu, F Stephen Hodi. Nat Rev Clin Oncol 2017
Mizuki Nishino, Nikhil H Ramaiya, Hiroto Hatabu, F Stephen Hodi. Nat Rev Clin Oncol 2017
15
Pseudoprogression and Immune-Related Response in Solid Tumors.
Victoria L Chiou, Mauricio Burotto. J Clin Oncol 2015
Victoria L Chiou, Mauricio Burotto. J Clin Oncol 2015
15
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.
Jarushka Naidoo, Xuan Wang, Kaitlin M Woo, Tunc Iyriboz, Darragh Halpenny, Jane Cunningham, Jamie E Chaft, Neil H Segal, Margaret K Callahan, Alexander M Lesokhin,[...]. J Clin Oncol 2017
Jarushka Naidoo, Xuan Wang, Kaitlin M Woo, Tunc Iyriboz, Darragh Halpenny, Jane Cunningham, Jamie E Chaft, Neil H Segal, Margaret K Callahan, Alexander M Lesokhin,[...]. J Clin Oncol 2017
15
14
Immune Checkpoint Inhibitor Cancer Therapy: Spectrum of Imaging Findings.
Gary X Wang, Vikram Kurra, Justin F Gainor, Ryan J Sullivan, Keith T Flaherty, Susanna I Lee, Florian J Fintelmann. Radiographics 2017
Gary X Wang, Vikram Kurra, Justin F Gainor, Ryan J Sullivan, Keith T Flaherty, Susanna I Lee, Florian J Fintelmann. Radiographics 2017
20
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Hossein Borghaei, Luis Paz-Ares, Leora Horn, David R Spigel, Martin Steins, Neal E Ready, Laura Q Chow, Everett E Vokes, Enriqueta Felip, Esther Holgado,[...]. N Engl J Med 2015
Hossein Borghaei, Luis Paz-Ares, Leora Horn, David R Spigel, Martin Steins, Neal E Ready, Laura Q Chow, Everett E Vokes, Enriqueta Felip, Esther Holgado,[...]. N Engl J Med 2015
14
Novel patterns of response under immunotherapy.
E Borcoman, Y Kanjanapan, S Champiat, S Kato, V Servois, R Kurzrock, S Goel, P Bedard, C Le Tourneau. Ann Oncol 2019
E Borcoman, Y Kanjanapan, S Champiat, S Kato, V Servois, R Kurzrock, S Goel, P Bedard, C Le Tourneau. Ann Oncol 2019
14
89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer.
Frederike Bensch, Elly L van der Veen, Marjolijn N Lub-de Hooge, Annelies Jorritsma-Smit, Ronald Boellaard, Iris C Kok, Sjoukje F Oosting, Carolina P Schröder, T Jeroen N Hiltermann, Anthonie J van der Wekken,[...]. Nat Med 2018
Frederike Bensch, Elly L van der Veen, Marjolijn N Lub-de Hooge, Annelies Jorritsma-Smit, Ronald Boellaard, Iris C Kok, Sjoukje F Oosting, Carolina P Schröder, T Jeroen N Hiltermann, Anthonie J van der Wekken,[...]. Nat Med 2018
13
Ipilimumab associated hepatitis: imaging and clinicopathologic findings.
Kyung Won Kim, Nikhil H Ramaiya, Katherine M Krajewski, Jyothi P Jagannathan, Sree Harsha Tirumani, Amitabh Srivastava, Nageatte Ibrahim. Invest New Drugs 2013
Kyung Won Kim, Nikhil H Ramaiya, Katherine M Krajewski, Jyothi P Jagannathan, Sree Harsha Tirumani, Amitabh Srivastava, Nageatte Ibrahim. Invest New Drugs 2013
13
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
Julie Brahmer, Karen L Reckamp, Paul Baas, Lucio Crinò, Wilfried E E Eberhardt, Elena Poddubskaya, Scott Antonia, Adam Pluzanski, Everett E Vokes, Esther Holgado,[...]. N Engl J Med 2015
Julie Brahmer, Karen L Reckamp, Paul Baas, Lucio Crinò, Wilfried E E Eberhardt, Elena Poddubskaya, Scott Antonia, Adam Pluzanski, Everett E Vokes, Esther Holgado,[...]. N Engl J Med 2015
13
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.
Daniel Y Wang, Joe-Elie Salem, Justine V Cohen, Sunandana Chandra, Christian Menzer, Fei Ye, Shilin Zhao, Satya Das, Kathryn E Beckermann, Lisa Ha,[...]. JAMA Oncol 2018
Daniel Y Wang, Joe-Elie Salem, Justine V Cohen, Sunandana Chandra, Christian Menzer, Fei Ye, Shilin Zhao, Satya Das, Kathryn E Beckermann, Lisa Ha,[...]. JAMA Oncol 2018
13
Radiologic manifestations of immune-related adverse events in patients with metastatic melanoma undergoing anti-CTLA-4 antibody therapy.
Yulia Bronstein, Chaan S Ng, Patrick Hwu, Wen-Jen Hwu. AJR Am J Roentgenol 2011
Yulia Bronstein, Chaan S Ng, Patrick Hwu, Wen-Jen Hwu. AJR Am J Roentgenol 2011
13
Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis.
Mizuki Nishino, Anita Giobbie-Hurder, Hiroto Hatabu, Nikhil H Ramaiya, F Stephen Hodi. JAMA Oncol 2016
Mizuki Nishino, Anita Giobbie-Hurder, Hiroto Hatabu, Nikhil H Ramaiya, F Stephen Hodi. JAMA Oncol 2016
13
Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer Care.
Mizuki Nishino, Hiroto Hatabu, Lynette M Sholl, Nikhil H Ramaiya. Radiographics 2017
Mizuki Nishino, Hiroto Hatabu, Lynette M Sholl, Nikhil H Ramaiya. Radiographics 2017
30
Cancer immunotherapy: imaging assessment of novel treatment response patterns and immune-related adverse events.
Jennifer J Kwak, Sree Harsha Tirumani, Annick D Van den Abbeele, Phillip J Koo, Heather A Jacene. Radiographics 2015
Jennifer J Kwak, Sree Harsha Tirumani, Annick D Van den Abbeele, Phillip J Koo, Heather A Jacene. Radiographics 2015
13
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.
Julie R Brahmer, Christina Lacchetti, Bryan J Schneider, Michael B Atkins, Kelly J Brassil, Jeffrey M Caterino, Ian Chau, Marc S Ernstoff, Jennifer M Gardner, Pamela Ginex,[...]. J Clin Oncol 2018
Julie R Brahmer, Christina Lacchetti, Bryan J Schneider, Michael B Atkins, Kelly J Brassil, Jeffrey M Caterino, Ian Chau, Marc S Ernstoff, Jennifer M Gardner, Pamela Ginex,[...]. J Clin Oncol 2018
13
Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1.
Stéphane Champiat, Laurent Dercle, Samy Ammari, Christophe Massard, Antoine Hollebecque, Sophie Postel-Vinay, Nathalie Chaput, Alexander Eggermont, Aurélien Marabelle, Jean-Charles Soria,[...]. Clin Cancer Res 2017
Stéphane Champiat, Laurent Dercle, Samy Ammari, Christophe Massard, Antoine Hollebecque, Sophie Postel-Vinay, Nathalie Chaput, Alexander Eggermont, Aurélien Marabelle, Jean-Charles Soria,[...]. Clin Cancer Res 2017
12
Immune-Related Tumor Response Dynamics in Melanoma Patients Treated with Pembrolizumab: Identifying Markers for Clinical Outcome and Treatment Decisions.
Mizuki Nishino, Anita Giobbie-Hurder, Michael P Manos, Nancy Bailey, Elizabeth I Buchbinder, Patrick A Ott, Nikhil H Ramaiya, F Stephen Hodi. Clin Cancer Res 2017
Mizuki Nishino, Anita Giobbie-Hurder, Michael P Manos, Nancy Bailey, Elizabeth I Buchbinder, Patrick A Ott, Nikhil H Ramaiya, F Stephen Hodi. Clin Cancer Res 2017
15
Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria.
M Tazdait, L Mezquita, J Lahmar, R Ferrara, F Bidault, S Ammari, C Balleyguier, D Planchard, A Gazzah, J C Soria,[...]. Eur J Cancer 2018
M Tazdait, L Mezquita, J Lahmar, R Ferrara, F Bidault, S Ammari, C Balleyguier, D Planchard, A Gazzah, J C Soria,[...]. Eur J Cancer 2018
12
Ipilimumab-associated colitis: CT findings.
Kyung Won Kim, Nikhil H Ramaiya, Katherine M Krajewski, Atul B Shinagare, Stephanie A Howard, Jyothi P Jagannathan, Nageatte Ibrahim. AJR Am J Roentgenol 2013
Kyung Won Kim, Nikhil H Ramaiya, Katherine M Krajewski, Atul B Shinagare, Stephanie A Howard, Jyothi P Jagannathan, Nageatte Ibrahim. AJR Am J Roentgenol 2013
12
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy.
Roberto Ferrara, Laura Mezquita, Matthieu Texier, Jihene Lahmar, Clarisse Audigier-Valette, Laurent Tessonnier, Julien Mazieres, Gerard Zalcman, Solenn Brosseau, Sylvestre Le Moulec,[...]. JAMA Oncol 2018
Roberto Ferrara, Laura Mezquita, Matthieu Texier, Jihene Lahmar, Clarisse Audigier-Valette, Laurent Tessonnier, Julien Mazieres, Gerard Zalcman, Solenn Brosseau, Sylvestre Le Moulec,[...]. JAMA Oncol 2018
12
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
Scott N Gettinger, Leora Horn, Leena Gandhi, David R Spigel, Scott J Antonia, Naiyer A Rizvi, John D Powderly, Rebecca S Heist, Richard D Carvajal, David M Jackman,[...]. J Clin Oncol 2015
Scott N Gettinger, Leora Horn, Leena Gandhi, David R Spigel, Scott J Antonia, Naiyer A Rizvi, John D Powderly, Rebecca S Heist, Richard D Carvajal, David M Jackman,[...]. J Clin Oncol 2015
12
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.
Michael A Postow, Robert Sidlow, Matthew D Hellmann. N Engl J Med 2018
Michael A Postow, Robert Sidlow, Matthew D Hellmann. N Engl J Med 2018
12
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers.
S Trebeschi, S G Drago, N J Birkbak, I Kurilova, A M Cǎlin, A Delli Pizzi, F Lalezari, D M J Lambregts, M W Rohaan, C Parmar,[...]. Ann Oncol 2019
S Trebeschi, S G Drago, N J Birkbak, I Kurilova, A M Cǎlin, A Delli Pizzi, F Lalezari, D M J Lambregts, M W Rohaan, C Parmar,[...]. Ann Oncol 2019
12
Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point 18F-FDG PET/CT Imaging in Patients with Advanced Melanoma.
Steve Y Cho, Evan J Lipson, Hyung-Jun Im, Steven P Rowe, Esther Mena Gonzalez, Amanda Blackford, Alin Chirindel, Drew M Pardoll, Suzanne L Topalian, Richard L Wahl. J Nucl Med 2017
Steve Y Cho, Evan J Lipson, Hyung-Jun Im, Steven P Rowe, Esther Mena Gonzalez, Amanda Blackford, Alin Chirindel, Drew M Pardoll, Suzanne L Topalian, Richard L Wahl. J Nucl Med 2017
11
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
11
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.
Roy S Herbst, Paul Baas, Dong-Wan Kim, Enriqueta Felip, José L Pérez-Gracia, Ji-Youn Han, Julian Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung-Ju Ahn,[...]. Lancet 2016
Roy S Herbst, Paul Baas, Dong-Wan Kim, Enriqueta Felip, José L Pérez-Gracia, Ji-Youn Han, Julian Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung-Ju Ahn,[...]. Lancet 2016
10
From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.
Richard L Wahl, Heather Jacene, Yvette Kasamon, Martin A Lodge. J Nucl Med 2009
Richard L Wahl, Heather Jacene, Yvette Kasamon, Martin A Lodge. J Nucl Med 2009
10
Frequency and imaging features of abdominal immune-related adverse events in metastatic lung cancer patients treated with PD-1 inhibitor.
Francesco Alessandrino, Sonia Sahu, Mizuki Nishino, Anika E Adeni, Sree Harsha Tirumani, Atul B Shinagare, Mark M Awad. Abdom Radiol (NY) 2019
Francesco Alessandrino, Sonia Sahu, Mizuki Nishino, Anika E Adeni, Sree Harsha Tirumani, Atul B Shinagare, Mark M Awad. Abdom Radiol (NY) 2019
38
18
Anti-PD-1-Related Pneumonitis during Cancer Immunotherapy.
Mizuki Nishino, Lynette M Sholl, F Stephen Hodi, Hiroto Hatabu, Nikhil H Ramaiya. N Engl J Med 2015
Mizuki Nishino, Lynette M Sholl, F Stephen Hodi, Hiroto Hatabu, Nikhil H Ramaiya. N Engl J Med 2015
10
Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Trials.
Monica Khunger, Sagar Rakshit, Vinay Pasupuleti, Adrian V Hernandez, Peter Mazzone, James Stevenson, Nathan A Pennell, Vamsidhar Velcheti. Chest 2017
Monica Khunger, Sagar Rakshit, Vinay Pasupuleti, Adrian V Hernandez, Peter Mazzone, James Stevenson, Nathan A Pennell, Vamsidhar Velcheti. Chest 2017
10
Immune Checkpoint Inhibitor Therapy-related Pneumonitis: Patterns and Management.
Kevin R Kalisz, Nikhil H Ramaiya, Kai R Laukamp, Amit Gupta. Radiographics 2019
Kevin R Kalisz, Nikhil H Ramaiya, Kai R Laukamp, Amit Gupta. Radiographics 2019
15
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
Tony S K Mok, Yi-Long Wu, Iveta Kudaba, Dariusz M Kowalski, Byoung Chul Cho, Hande Z Turna, Gilberto Castro, Vichien Srimuninnimit, Konstantin K Laktionov, Igor Bondarenko,[...]. Lancet 2019
Tony S K Mok, Yi-Long Wu, Iveta Kudaba, Dariusz M Kowalski, Byoung Chul Cho, Hande Z Turna, Gilberto Castro, Vichien Srimuninnimit, Konstantin K Laktionov, Igor Bondarenko,[...]. Lancet 2019
9
Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1.
Ahmed Mekki, Laurent Dercle, Philip Lichtenstein, Aurélien Marabelle, Jean-Marie Michot, Olivier Lambotte, Jérôme Le Pavec, Eleonora De Martin, Corinne Balleyguier, Stéphane Champiat,[...]. Eur J Cancer 2018
Ahmed Mekki, Laurent Dercle, Philip Lichtenstein, Aurélien Marabelle, Jean-Marie Michot, Olivier Lambotte, Jérôme Le Pavec, Eleonora De Martin, Corinne Balleyguier, Stéphane Champiat,[...]. Eur J Cancer 2018
11
Novel clinical and radiomic predictors of rapid disease progression phenotypes among lung cancer patients treated with immunotherapy: An early report.
Ilke Tunali, Jhanelle E Gray, Jin Qi, Mahmoud Abdalah, Daniel K Jeong, Albert Guvenis, Robert J Gillies, Matthew B Schabath. Lung Cancer 2019
Ilke Tunali, Jhanelle E Gray, Jin Qi, Mahmoud Abdalah, Daniel K Jeong, Albert Guvenis, Robert J Gillies, Matthew B Schabath. Lung Cancer 2019
11
Pembrolizumab for the treatment of non-small-cell lung cancer.
Edward B Garon, Naiyer A Rizvi, Rina Hui, Natasha Leighl, Ani S Balmanoukian, Joseph Paul Eder, Amita Patnaik, Charu Aggarwal, Matthew Gubens, Leora Horn,[...]. N Engl J Med 2015
Edward B Garon, Naiyer A Rizvi, Rina Hui, Natasha Leighl, Ani S Balmanoukian, Joseph Paul Eder, Amita Patnaik, Charu Aggarwal, Matthew Gubens, Leora Horn,[...]. N Engl J Med 2015
9
Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy.
F Stephen Hodi, Marcus Ballinger, Benjamin Lyons, Jean-Charles Soria, Mizuki Nishino, Josep Tabernero, Thomas Powles, David Smith, Axel Hoos, Chris McKenna,[...]. J Clin Oncol 2018
F Stephen Hodi, Marcus Ballinger, Benjamin Lyons, Jean-Charles Soria, Mizuki Nishino, Josep Tabernero, Thomas Powles, David Smith, Axel Hoos, Chris McKenna,[...]. J Clin Oncol 2018
9
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
J B A G Haanen, F Carbonnel, C Robert, K M Kerr, S Peters, J Larkin, K Jordan. Ann Oncol 2017
J B A G Haanen, F Carbonnel, C Robert, K M Kerr, S Peters, J Larkin, K Jordan. Ann Oncol 2017
9
Incidence of Pseudoprogression during Immune Checkpoint Inhibitor Therapy for Solid Tumors: A Systematic Review and Meta-Analysis.
Hyo Jung Park, Kyung Won Kim, Junhee Pyo, Chong Hyun Suh, Shinkyo Yoon, Hiroto Hatabu, Mizuki Nishino. Radiology 2020
Hyo Jung Park, Kyung Won Kim, Junhee Pyo, Chong Hyun Suh, Shinkyo Yoon, Hiroto Hatabu, Mizuki Nishino. Radiology 2020
23
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.